AI Investing Insights - Official Homepage

News

4.0

01-06aastocks

CICC Begins Coverage of YUE YUEN IND with Outperform Rating and Target Price of HKD 19.46

6.0

01-02aastocks

CICC Begins Coverage of YUE YUEN IND (00551.HK) with Outperform Rating and Target Price of $19.46

7.5

2025-12-10aastocks

YUE YUEN IND Reports 3.1% Year-over-Year Decline in November Net Consolidated Operating Revenue

6.5

2025-12-01aastocks

<Research> CLSA Names ANTA SPORTS, YUE YUEN INDUSTRIES, and SAMSONITE as Consumer Favorites

4.0

2025-12-01aastocks

<Study>CLSA Consumer Ratings and Target Prices (Table)

Money Flow

Over the past 66 trading days, overall net money flow is 27.24M, with retail investors contributing 14.89M and major investors adding -5.26M.

Net Buy $ Volume

Net Sell $ Volume

CICC

Outperform

initiated

$19.46

2026-01-06

Reason

The analyst rating of "Outperform" for YUE YUEN IND (00551.HK) is based on the assessment that the company's sports shoe business has significant potential and a concentrated market structure. The report highlights YUE YUEN IND's position as a leading manufacturer in the sports shoe sector and its involvement in the sports apparel retail business. Additionally, the company's development capabilities are seen as a factor that can secure high-quality growth clients, further supporting the positive outlook.

CICC

Outperform

Price Target

$19.46

2026-01-06

initiated

The analyst rating of "Outperform" for YUE YUEN IND (00551.HK) is based on the assessment that the company's sports shoe business has significant potential and a concentrated market structure. The report highlights YUE YUEN IND's position as a leading manufacturer in the sports shoe sector and its involvement in the sports apparel retail business. Additionally, the company's development capabilities are seen as a factor that can secure high-quality growth clients, further supporting the positive outlook.

CICC

Outperform

initiated

$19.46

2026-01-02

Reason

The analyst rating of "Outperform" for YUE YUEN IND (00551.HK) is based on several key factors: 1. Market Leadership: YUE YUEN IND is recognized as the world's largest sports shoe manufacturer, which positions it favorably within the global sports shoe market. 2. Growth Potential: The global sports shoe market is projected to grow at a mid-single-digit rate over the next five years, indicating a stable demand environment. 3. Concentration in the Industry: The concentration of market share among the top brands suggests that YUE YUEN IND, with an estimated shipment share exceeding 10%, is well-placed to benefit from this trend. 4. Retail Expansion: The company's subsidiary, Pou Sheng International, is a leading sports shoe and apparel retailer in Greater China, which enhances its growth prospects in a significant market. 5. Valuation: The target price of $19.46 corresponds to a 10.5x PE ratio for 2026, suggesting that the stock is expected to perform well relative to its earnings potential. Overall, the combination of market leadership, growth potential, and strategic positioning in retail supports the positive analyst rating.

CICC

Outperform

Price Target

$19.46

2026-01-02

initiated

The analyst rating of "Outperform" for YUE YUEN IND (00551.HK) is based on several key factors: 1. Market Leadership: YUE YUEN IND is recognized as the world's largest sports shoe manufacturer, which positions it favorably within the global sports shoe market. 2. Growth Potential: The global sports shoe market is projected to grow at a mid-single-digit rate over the next five years, indicating a stable demand environment. 3. Concentration in the Industry: The concentration of market share among the top brands suggests that YUE YUEN IND, with an estimated shipment share exceeding 10%, is well-placed to benefit from this trend. 4. Retail Expansion: The company's subsidiary, Pou Sheng International, is a leading sports shoe and apparel retailer in Greater China, which enhances its growth prospects in a significant market. 5. Valuation: The target price of $19.46 corresponds to a 10.5x PE ratio for 2026, suggesting that the stock is expected to perform well relative to its earnings potential. Overall, the combination of market leadership, growth potential, and strategic positioning in retail supports the positive analyst rating.

CLSA

upgrade

$16 -> $18

2025-12-01

Reason

The analyst rating from CLSA is based on the expectation that China's consumption sector will focus on niche market development, with the high-end consumption market benefiting from easing monetary policy, improvements in the stock market, and recovery in offshore financing. They anticipate moderate consumption sentiment and CPI data, while companies are expected to capitalize on opportunities in large-scale niche markets, globalization, and high-end consumption recovery. This outlook has led CLSA to identify specific stocks, such as ANTA SPORTS, YUE YUEN IND, and SAMSONITE, as top picks, while also adjusting target prices for others like POP MART based on anticipated catalysts.

CLSA

Price Target

$16 -> $18

2025-12-01

upgrade

The analyst rating from CLSA is based on the expectation that China's consumption sector will focus on niche market development, with the high-end consumption market benefiting from easing monetary policy, improvements in the stock market, and recovery in offshore financing. They anticipate moderate consumption sentiment and CPI data, while companies are expected to capitalize on opportunities in large-scale niche markets, globalization, and high-end consumption recovery. This outlook has led CLSA to identify specific stocks, such as ANTA SPORTS, YUE YUEN IND, and SAMSONITE, as top picks, while also adjusting target prices for others like POP MART based on anticipated catalysts.

UBS

NULL -> Buy

upgrade

$18

2025-12-01

Reason

UBS issued a Buy rating on YUE YUEN IND (00551.HK) based on several positive factors. The analyst noted an improvement in OEM margins in the third quarter compared to the first half of the year, attributed to reduced overtime, increased worker familiarity with orders, and a more stable US tariff policy. Additionally, UBS observed that some orders were likely brought forward to the fourth quarter for production. While they expect a year-over-year decline in sales volume for the fourth quarter, they anticipate an increase in average selling price (ASP). Looking ahead to 2026, UBS believes that the recovery of individual brands could benefit YUE YUEN IND, and they expect vibrant sales during the upcoming holiday season, which could enhance brand confidence and attract new clients. Consequently, UBS raised its target price for the company from HK$18 to HK$18.4.

UBS

NULL -> Buy

Price Target

$18

2025-12-01

upgrade

UBS issued a Buy rating on YUE YUEN IND (00551.HK) based on several positive factors. The analyst noted an improvement in OEM margins in the third quarter compared to the first half of the year, attributed to reduced overtime, increased worker familiarity with orders, and a more stable US tariff policy. Additionally, UBS observed that some orders were likely brought forward to the fourth quarter for production. While they expect a year-over-year decline in sales volume for the fourth quarter, they anticipate an increase in average selling price (ASP). Looking ahead to 2026, UBS believes that the recovery of individual brands could benefit YUE YUEN IND, and they expect vibrant sales during the upcoming holiday season, which could enhance brand confidence and attract new clients. Consequently, UBS raised its target price for the company from HK$18 to HK$18.4.

Goldman Sachs

Buy

maintain

2025-11-17

Reason

The analyst rating from Goldman Sachs for YUE YUEN IND was kept at "Buy" due to several factors. The company's share price rallied post-results, indicating better-than-expected profit margins for 3Q25. Goldman Sachs raised its profit margin forecasts, attributing this to the company's effective flexible order allocation and cost savings in sales and administrative expenses. Additionally, the broker increased its net profit projections for 2025-2027 by 7-11% and raised the target price from $14.8 to $16.9, reflecting a positive outlook despite potential challenges in OEM sales and profit margins in the upcoming quarters.

Goldman Sachs

Buy

Price Target

2025-11-17

maintain

The analyst rating from Goldman Sachs for YUE YUEN IND was kept at "Buy" due to several factors. The company's share price rallied post-results, indicating better-than-expected profit margins for 3Q25. Goldman Sachs raised its profit margin forecasts, attributing this to the company's effective flexible order allocation and cost savings in sales and administrative expenses. Additionally, the broker increased its net profit projections for 2025-2027 by 7-11% and raised the target price from $14.8 to $16.9, reflecting a positive outlook despite potential challenges in OEM sales and profit margins in the upcoming quarters.

UBS

Hold

to

Buy

upgrade

$16 -> $18

2025-11-17

Reason

The analyst rating for YUE YUEN IND was upgraded to "Buy" by UBS due to an increase in the target price from HKD 16 to HKD 18. This adjustment was based on a revised net profit forecast for 2025-27, which was raised by 5-6% to account for better-than-expected OEM gross profit margins (GPM). Despite a year-over-year decline in revenue and net profit, the positive outlook on profit margins led to the rating upgrade.

UBS

Hold

to

Buy

Price Target

$16 -> $18

2025-11-17

upgrade

The analyst rating for YUE YUEN IND was upgraded to "Buy" by UBS due to an increase in the target price from HKD 16 to HKD 18. This adjustment was based on a revised net profit forecast for 2025-27, which was raised by 5-6% to account for better-than-expected OEM gross profit margins (GPM). Despite a year-over-year decline in revenue and net profit, the positive outlook on profit margins led to the rating upgrade.

Jefferies

Buy

to

Underperform

downgrade

$8

2025-08-12

Reason

Jefferies

Buy

to

Underperform

Price Target

$8

2025-08-12

downgrade

Valuation Metrics

Forward PE

5Y Average PE

8.93

Current PE

8.70

Overvalued PE

14.17

Undervalued PE

3.70

Forward EV/EBITDA

5Y Average EV/EBITDA

4.51

Current EV/EBITDA

4.97

Overvalued EV/EBITDA

6.18

Undervalued EV/EBITDA

2.85

Forward PS

5Y Average PS

0.29

Current PS

0.39

Overvalued PS

0.39

Undervalued PS

0.20

Financials

Al Analysis

Annual

Quarterly

Trading Trends

Daily

Monthly

Buyback

Short Selling

People Also Watch